CompletedNCT02053831

GalaFlex Mesh in Facelift

Studying Superior mesenteric artery syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
C. R. Bard
Principal Investigator
Arikha Moses, Ph.D
Chief Scientific Officer, Founder
Enrollment
15 target
Eligibility
21-99 years · All sexes
Timeline
20112014

Study locations (3)

Collaborators

Tepha, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02053831 on ClinicalTrials.gov

Other trials for Superior mesenteric artery syndrome

Additional recruiting or active studies for the same condition.

See all trials for Superior mesenteric artery syndrome

← Back to all trials